首页> 外文OA文献 >Tyrosines 868, 966, and 972 in the Kinase Domain of JAK2 Are Autophosphorylated and Required for Maximal JAK2 Kinase Activity
【2h】

Tyrosines 868, 966, and 972 in the Kinase Domain of JAK2 Are Autophosphorylated and Required for Maximal JAK2 Kinase Activity

机译:JAK2激酶结构域中的酪氨酸868、966和972是自动磷酸化的,是最大JAK2激酶活性所必需的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Janus kinase 2 (JAK2) is activated by a majority of cytokine family receptors including receptors for GH, leptin, and erythropoietin. To identify novel JAK2-regulatory and/or -binding sites, we set out to identify autophosphorylation sites in the kinase domain of JAK2. Two-dimensional phosphopeptide mapping of in vitro autophosphorylated JAK2 identified tyrosines 868, 966, and 972 as sites of autophosphorylation. Phosphorylated tyrosines 868 and 972 were also identified by mass spectrometry analysis of JAK2 activated by an erythropoietin-bound chimeric erythropoietin receptor/leptin receptor. Phosphospecific antibodies suggest that the phosphorylation of all three tyrosines increases in response to GH. Compared with wild-type JAK2, which is constitutively active when overexpressed, JAK2 lacking tyrosine 868, 966, or 972 has substantially reduced activity. Coexpression with GH receptor and protein tyrosine phosphatase1B allowed us to investigate GH-dependent activation of these mutated JAK2s in human embryonic kidney 293T cells. All three mutated JAK2s are activated by GH, although to a lesser extent than wild-type JAK2. The three mutated JAK2s also mediate GH activation of signal transducer and activator of transcription 3 (Stat3), signal transducer and activator of transcription 5b (Stat5b) and ERK1, but at reduced levels. Coexpression with Src-homology 2B1β (SH2B1β), like coexpression with GH-bound GH receptor, partially restores the activity of all three JAK2 mutants. Based on these results and the crystal structure of the JAK2 kinase domain, we hypothesize that small changes in the conformation of the regions of JAK2 surrounding tyrosines 868, 966, and 972 due to e.g. phosphorylation, binding to a ligand-bound cytokine receptor, and/or binding to Src-homology 2B1, may be essential for JAK2 to assume a maximally active conformation.
机译:Janus激酶2(JAK2)被大多数细胞因子家族受体(包括GH,瘦蛋白和促红细胞生成素的受体)激活。为了鉴定新的JAK2调节和/或结合位点,我们着手鉴定JAK2的激酶结构域中的自磷酸化位点。体外自磷酸化JAK2的二维磷酸肽图谱将酪氨酸868、966和972确定为自磷酸化位点。还通过质谱分析鉴定了磷酸化的酪氨酸868和972,所述JAK2被促红细胞生成素结合的嵌合促红细胞生成素受体/瘦蛋白受体激活。磷酸化特异性抗体表明,所有三种酪氨酸的磷酸化均响应GH而增加。与野生型JAK2(过表达时具有组成性活性)相比,缺少酪氨酸868、966或972的JAK2的活性大大降低。与GH受体和蛋白酪氨酸磷酸酶1B的共表达使我们能够研究人胚胎肾293T细胞中这些突变JAK2s的GH依赖性激活。所有三个突变的JAK2均被GH激活,尽管程度低于野生型JAK2。这三个突变的JAK2还介导了GH信号转导和转录激活因子3(Stat3),信号转导和转录激活因子5b(Stat5b)和ERK1的GH激活,但水平降低。与Src同源2B1β(SH2B1β)共表达,与与GH结合的GH受体共表达一样,部分恢复了所有三个JAK2突变体的活性。基于这些结果和JAK2激酶结构域的晶体结构,我们假设酪氨酸868、966和972周围的JAK2区域的构象的微小变化是由于例如H.O.等引起的。磷酸化,与配体结合的细胞因子受体结合和/或与Src同源2B1结合可能对于JAK2呈现最大活性构象至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号